Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Nuclear Medicine

  Free Subscription

Articles published in Brain

Retrieve available abstracts of 31 articles:
HTML format

Single Articles

    September 2022
  1. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  2. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    PubMed     Abstract available

    June 2022
  3. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    PubMed     Abstract available

    April 2022
  4. ALSHELH Z, Brusaferri L, Saha A, Morrissey E, et al
    Neuroimmune signatures in chronic low back pain subtypes.
    Brain. 2022;145:1098-1110.
    PubMed     Abstract available

    February 2022
  5. ANG YS, Cusin C, Petibon Y, Dillon DG, et al
    A multi-pronged investigation of option generation using depression, PET and modafinil.
    Brain. 2022 Feb 12. pii: 6527662. doi: 10.1093.
    PubMed     Abstract available

    January 2022
  6. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available

  7. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    PubMed     Abstract available

    December 2021
  8. REINARTZ M, Gabel S, Schaeverbeke J, Meersmans K, et al
    Changes in the language system as amyloid-beta accumulates.
    Brain. 2021;144:3756-3768.
    PubMed     Abstract available

  9. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    PubMed     Abstract available

  10. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available

  11. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available

  12. HERMANIDES J, Hong YT, Trivedi M, Outtrim J, et al
    Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury.
    Brain. 2021;144:3492-3504.
    PubMed     Abstract available

    November 2021
  13. YAN S, Zheng C, Paranjpe MD, Li Y, et al
    Sex modifies APOE epsilon4 dose effect on brain tau deposition in cognitively impaired individuals.
    Brain. 2021;144:3201-3211.
    PubMed     Abstract available

    October 2021
  14. DOPPLER CEJ, Kinnerup MB, Brune C, Farrher E, et al
    Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Brain. 2021;144:2732-2744.
    PubMed     Abstract available

  15. BERRON D, Vogel JW, Insel PS, Pereira JB, et al
    Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.
    Brain. 2021;144:2771-2783.
    PubMed     Abstract available

  16. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available

  17. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available

    August 2021
  18. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available

  19. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available

    July 2021
  20. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available

    June 2021
  21. WALSH J, Tozer DJ, Sari H, Hong YT, et al
    Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Brain. 2021;144:1361-1371.
    PubMed     Abstract available

  22. ZHOU L, Li G, Zhang Y, Zhang M, et al
    Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Brain. 2021;144:1488-1497.
    PubMed     Abstract available

  23. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available

    May 2021
  24. HOSP JA, Dressing A, Blazhenets G, Bormann T, et al
    Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.
    Brain. 2021;144:1263-1276.
    PubMed     Abstract available

    April 2021
  25. MAZERE J, Dilharreguy B, Catheline G, Vidailhet M, et al
    Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia.
    Brain. 2021;144:909-923.
    PubMed     Abstract available

  26. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.

  27. PASCUAL B, Funk Q, Zanotti-Fregonara P, Cykowski MD, et al
    Neuroinflammation is highest in areas of disease progression in semantic dementia.
    Brain. 2021 Apr 6. pii: 6213358. doi: 10.1093.
    PubMed     Abstract available

    March 2021
  28. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available

    February 2021
  29. ARNALDI D, Chincarini A, Hu MT, Sonka K, et al
    Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Brain. 2021;144:278-287.
    PubMed     Abstract available

    December 2020
  30. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available

    November 2020
  31. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.